who can use glp 1 for weight loss Comparing GLP‑1 Drugs With Other Methods: Diet & Exercise, Bariatric Surgery, and Lifestyle Programs -Pros & Cons GLP-1 Medications Explained: A Doctor's

doi: 10.1053/j.gastro.2004.07.024 89 AtarashiKTanoueTShimaTImaokaAKuwaharaTMomoseYet al

Conclusion RYGB surgery accelerates large intestinal fermentation of inulin, however, without measurable effects on plasma SCFAs or plasma GLP-1 and PYY

Research in the Journal of Clinical Endocrinology & Metabolism has shown that sustained GH elevation even modest increases significantly impacts visceral fat reduction and lean mass preservation in adults with age-related GH decline (Rudman et al., 1990, NEJM )

In December 2024, NICE recommended the use of tirzepatide (Mounjaro), alongside semaglutide (Wegovy) and liraglutide (Saxenda), for the treatment of weight-related comorbidities.10 NICE recommended these drugs alongside diet and exercise, yet many patients lack structured programs offering nutritional, behavioural, and psychological support